Enhanced RANKL expression is also implicated in bone destruction in multiple myeloma patients.[16] OCGs are frequently seen in tenosynovial giant cell tumor, pigmented villonodular synovitis and giant cell tumor of bone. The gene discussed is TNFSF11; the disease is pigmented villonodular synovitis.